Today, U.S. Markets are closed for Thanksgiving Day.
On Wednesday, Itau Unibanco Holding SA (ADR) (NYSE:ITUB)’s shares declined -6.54% to $7.36.
ITUB has 27.70% institutional ownership while its EPS ratio was 1.24. The company has 2.90 billion shares outstanding while market capitalization of the company was $45.77 billion. Price to book ratio was 1.52. Net profit margin of the company was 18.50%. Stock volatility for the month was booked as 3.50% while for the week was recorded as 3.78%.
The mean estimate for the short term price target for Itau Unibanco Holding SA (ADR) (NYSE:ITUB) stands at $9.06 according to 7 Analysts. The higher price target estimate for the stock has been calculated at $13.59. while the lower price target estimate is at $7.10.
Analysts mean recommendation for the stock is 2.30. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Itau Unibanco Holding S.A. (Itau Unibanco Holding) is a holding company. The Company provides a range of financial products and services to individual and corporate clients in Brazil.
Keurig Green Mountain Inc (NASDAQ:GMCR)’s shares gained 8.00% to $52.76.
So far in 2015, the company has a year-to-date performance of -60.15%. The stock, as of last close, traded 32.56% up from its 52 week low and was -62.93% below its 52 week high. Its latest closing price was -34.76% below the SMA200 while the distance from SMA 50 and SMA 20 was 1.05% and 8.72% respectively.
The mean estimate for the short term price target for Keurig Green Mountain Inc (NASDAQ:GMCR) stands at $56.50 according to 12 Analysts. The higher price target estimate for the stock has been calculated at $90.00 while the lower price target estimate is at $46.00.
Analysts mean recommendation for the stock is 2.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Keurig Green Mountain, Inc. is a personal beverage system company. The Company is engaged in producing specialty coffee, coffeemakers, teas and other beverages in the United States and Canada.
At the end of Wednesday’s trade, ImmunoGen, Inc. (NASDAQ:IMGN)‘s shares surged 7.17% to $13.76.
IMGN has market capitalization of $1.12 billion. Its current ratio was 7.30 while its shares were above its 50 days simple moving average with 17.22%. The company offered earning per share of $-0.84 while its 86.98 million shares were outstanding. YTD performance of the company was 125.57%. Stock volatility for the week was 5.30% while for the month it was shown at 6.29%.
The mean estimate for the short term price target for ImmunoGen, Inc. (NASDAQ:IMGN) stands at $15.80 according to 10 Analysts. The higher price target estimate for the stock has been calculated at $24.00 while the lower price target estimate is at $8.00.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
ImmunoGen, Inc. (ImmunoGen) is a clinical-stage biotechnology company focused on the development of targeted anticancer therapeutics. The Company’s clinical and preclinical product candidates are antibody-drug conjugates (ADCs), which is a type of medicine that uses a monoclonal antibody to deliver a therapeutic agent to targeted cells.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.